,
Lotta, Luca A.
Pietzner, Maik
Stewart, Isobel D.
Wittemans, Laura B. L.
Li, Chen
Bonelli, Roberto
Raffler, Johannes http://orcid.org/0000-0003-2495-4020
Biggs, Emma K.
Oliver-Williams, Clare
Auyeung, Victoria P. W. http://orcid.org/0000-0002-0823-3963
Luan, Jian’an http://orcid.org/0000-0003-3137-6337
Wheeler, Eleanor http://orcid.org/0000-0002-8616-6444
Paige, Ellie http://orcid.org/0000-0003-0855-9872
Surendran, Praveen
Michelotti, Gregory A.
Scott, Robert A. http://orcid.org/0000-0003-3634-3016
Burgess, Stephen http://orcid.org/0000-0001-5365-8760
Zuber, Verena http://orcid.org/0000-0001-9827-1877
Sanderson, Eleanor http://orcid.org/0000-0001-5188-5775
Koulman, Albert http://orcid.org/0000-0001-9998-051X
Imamura, Fumiaki http://orcid.org/0000-0002-6841-8396
Forouhi, Nita G. http://orcid.org/0000-0002-5041-248X
Khaw, Kay-Tee
Griffin, Julian L.
Wood, Angela M.
Kastenmüller, Gabi http://orcid.org/0000-0002-2368-7322
Danesh, John
Butterworth, Adam S. http://orcid.org/0000-0002-6915-9015
Gribble, Fiona M.
Reimann, Frank http://orcid.org/0000-0001-9399-6377
Bahlo, Melanie http://orcid.org/0000-0001-5132-0774
Fauman, Eric http://orcid.org/0000-0002-9739-0249
Wareham, Nicholas J. http://orcid.org/0000-0003-1422-2993
Langenberg, Claudia http://orcid.org/0000-0002-5017-7344
Article History
Received: 4 February 2020
Accepted: 20 November 2020
First Online: 7 January 2021
Competing interests
: A.S.B. received grants from AstraZeneca, Biogen, Bioverativ, Merck, Novartis and Sanofi. J.D. sits on the International Cardiovascular and Metabolic Advisory Board for Novartis (since 2010), the Steering Committee of UK Biobank (since 2011), is a member of the MRC International Advisory Group, London (since 2013), the MRC High Throughput Science ’Omics Panel, London (since 2013) and serves on the Scientific Advisory Committee for Sanofi (since 2013), the International Cardiovascular and Metabolism Research and Development Portfolio Committee for Novartis and the AstraZeneca Genomics Advisory Board (since 2018). E.F. is an employee and stock holder of Pfizer. L.A.L. is presently an employee and shareholder of Regeneron Pharmaceuticals Inc. The remaining authors declare no competing interests.